Journal article

Third-generation antidepressants - Do they offer advantages over the SSRIs?

JS Olver, GD Burrows, TR Norman

CNS Drugs | ADIS INT LTD | Published : 2001

DOI: 10.2165/00023210-200115120-00004

Citation metrics

50Web of Science
60Scopus
49Dimensions

Keywords

Double-Blind
Depressive Disorder
Psychiatry
Neurosciences & Neurology
Pharmacokinetic Interaction
Clinical Neurology
Major Depressive Disorder
Long-Term Treatment
Humans
Mirtazapine
Science & Technology
Hospitalized-Patients
Placebo-Controlled Trial
Life Sciences & Biomedicine
Clinical Trials As Topic
Extended-Release Xr
Pharmacology & Pharmacy
Venlafaxine
In-Vitro
Serotonin Uptake Inhibitors
Secondary Prevention
Antidepressive Agents